298 related articles for article (PubMed ID: 26303825)
1. Lymph node evaluation for treatment of adenocarcinoma of the pancreas.
Marmor S; Burke EE; Portschy PR; Virnig BA; Jensen EH; Tuttle TM
Surg Oncol; 2015 Sep; 24(3):284-91. PubMed ID: 26303825
[TBL] [Abstract][Full Text] [Related]
2. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
4. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
7. Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer.
Gleisner AL; Spolverato G; Ejaz A; Pawlik TM
J Surg Oncol; 2014 Dec; 110(7):858-63. PubMed ID: 24975984
[TBL] [Abstract][Full Text] [Related]
8. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
9. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.
Schwarz RE; Smith DD
Ann Surg Oncol; 2006 Sep; 13(9):1189-200. PubMed ID: 16955385
[TBL] [Abstract][Full Text] [Related]
10. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
11. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
12. Lymph node evaluation in colorectal cancer patients: a population-based study.
Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
[TBL] [Abstract][Full Text] [Related]
13. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.
Garcia B; Guzman C; Johnson C; Hellenthal NJ; Monie D; Monzon JR
Surg Oncol; 2016 Sep; 25(3):158-63. PubMed ID: 27566017
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
[TBL] [Abstract][Full Text] [Related]
15. Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.
Prenzel KL; Hölscher AH; Vallböhmer D; Drebber U; Gutschow CA; Mönig SP; Stippel DL
Eur J Surg Oncol; 2010 Oct; 36(10):993-6. PubMed ID: 20594789
[TBL] [Abstract][Full Text] [Related]
16. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
[TBL] [Abstract][Full Text] [Related]
17. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
18. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.
Liu ZQ; Xiao ZW; Luo GP; Liu L; Liu C; Xu J; Long J; Ni QX; Yu XJ
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):634-41. PubMed ID: 25475867
[TBL] [Abstract][Full Text] [Related]
19. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years.
Parsons HM; Tuttle TM; Kuntz KM; Begun JW; McGovern PM; Virnig BA
JAMA; 2011 Sep; 306(10):1089-97. PubMed ID: 21917579
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]